Australia Medical Gas and Equipment Market Overview,2030

The medical gas and equipment market in Australia has evolved rapidly over the past three decades, supported by the country’s robust healthcare system and strict regulatory oversight under the Therapeutic Goods Administration and Standards Australia. Hospitals such as Royal Prince Alfred Hospital in Sydney and The Alfred Hospital in Melbourne were among the first to install centralized medical gas pipeline systems in the 1990s, replacing traditional cylinder-based setups with automated networks for oxygen, medical air, nitrous oxide, nitrogen, and carbon dioxide. These gases play a vital role in anesthesia, intensive care, and emergency medicine across both urban and regional facilities. The rise in respiratory diseases, particularly chronic obstructive pulmonary disease and sleep apnea, has driven growing oxygen demand, with over 7.5% of Australians affected by respiratory illnesses according to the Australian Institute of Health and Welfare. The expansion of critical care capacity through programs like the National Health Reform Agreement has encouraged hospitals to invest in PSA-based on-site oxygen generation plants, reducing dependence on bulk liquid supply in remote areas such as Western Australia and the Northern Territory. Cryogenic storage tanks and high-efficiency manifold systems are now standard installations in tertiary hospitals, equipped with alarm and monitoring technology integrated into building management systems. Smart gas delivery controls with IoT sensors are being used to track purity and pressure in real time, ensuring safety and reliability under AS 2896 standards for medical gas systems. Environmental considerations have become central to production, with companies adopting energy-efficient air separation units and cylinder recycling protocols to lower carbon emissions. Training initiatives led by the Australian Medical Engineering Association ensure hospital technicians and maintenance staffs are certified in gas handling, safety, and system calibration.

According to the research report, ""Australia Medical Gas and Equipment Market Overview, 2030,"" published by Bonafide Research, the Australia Medical Gas and Equipment market was valued at more than USD 130 Million in 2024. The medical gas and equipment market in Australia continues to expand through strong collaboration between public healthcare networks, private manufacturers, and research institutions. Leading players such as Air Liquide Healthcare Australia, BOC Healthcare, and Air Water Australia dominate gas production and distribution, supplying oxygen and medical air to hospitals, aged care facilities, and home healthcare providers nationwide. The COVID-19 pandemic prompted the establishment of rapid oxygen expansion projects, including on-site generation systems at Westmead Hospital in New South Wales and the Royal Brisbane and Women’s Hospital in Queensland, ensuring uninterrupted supply during surges in ICU occupancy. BOC Healthcare introduced automated monitoring systems and telemetry-equipped cylinders to improve logistics efficiency and maintain real-time supply visibility across rural hospitals. Air Liquide partnered with the Australian Department of Health to modernize hospital manifold systems and deploy cryogenic bulk storage in regional healthcare centers. In the home healthcare sector, companies like Supagas and Invacare Australia have expanded the use of portable oxygen concentrators, supported by the federal Home Oxygen Program that assists patients with long-term respiratory conditions. Startups such as OxiSure Medical and Meditech Gas Systems have entered the market with compact, low-maintenance concentrators designed for mobile use and telehealth integration. The logistics network for medical gas transportation has been strengthened through cryogenic transport fleets and automated refill hubs in South Australia and Tasmania. Universities such as the University of Sydney and Monash University are conducting research into AI-enabled gas monitoring systems and low-energy cryogenic storage for biopharmaceutical and research applications. Government funding under the Medical Research Future Fund has encouraged innovation in gas purification and biotechnology integration.

In Australia the medical gases and equipment market operates through two interconnected segments that form the foundation of the country’s healthcare infrastructure. The first is the medical gases segment which includes the production and distribution of oxygen, nitrous oxide, carbon dioxide, nitrogen and medical air that are supplied to hospitals, clinics and home-care providers across states such as New South Wales, Victoria and Queensland. Companies like Air Liquide Healthcare and Coregas Australia manage gas manufacturing and nationwide logistics networks that supply tertiary hospitals such as Royal Prince Alfred Hospital in Sydney and Alfred Health in Melbourne with bulk liquid storage systems and cylinder networks. The second segment is the medical gas equipment sector which involves regulators, flowmeters, manifolds, vacuum pumps, humidifiers, pipeline systems, alarm monitors and portable concentrators. These are installed and maintained in both large hospitals and smaller health facilities ensuring continuous supply and safety. Equipment producers and service providers in Australia work under strict standards such as AS 2896 which governs the design and maintenance of medical gas pipeline systems. Hospitals in Canberra and Adelaide use central manifold systems and automated switchover panels while home-care settings in regional areas of Tasmania and Western Australia rely on portable concentrators and modular units designed for patient mobility. The relationship between gases and equipment is crucial because every medical gas must be delivered through safe, precise and compatible hardware. As a result Australian healthcare infrastructure integrates industrial-scale gas production with highly engineered delivery and monitoring systems that support patient care from intensive hospital wards to home-based treatments.

In Australia medical gases and equipment have diverse applications across therapeutic, diagnostic, pharmaceutical and other areas of healthcare delivery. Therapeutically oxygen therapy and medical air are vital for patients with chronic obstructive pulmonary disease, post-surgical recovery and acute respiratory distress in hospitals such as Fiona Stanley Hospital in Perth and St Vincent’s in Sydney where large central gas systems and ventilators depend on precise delivery equipment. Diagnostic applications use gases like carbon dioxide for laparoscopic insufflation in surgical theatres in Brisbane and helium in magnetic resonance imaging systems for magnet cooling. Laboratories in institutions such as the Royal Brisbane and Women’s Hospital employ calibration gas mixtures for blood gas analyzers and testing instruments. The pharmaceutical industry in Victoria and South Australia relies on nitrogen and oxygen for sterile manufacturing and biotechnology production in facilities located in industrial clusters around Melbourne’s Dandenong and Adelaide’s Thebarton precinct. Other applications include nitrous oxide for dental sedation clinics, vacuum systems for emergency medical vehicles and portable oxygen units for home-healthcare programs supporting aged and palliative patients across Queensland’s rural areas. Australia’s regulatory oversight under the Therapeutic Goods Administration ensures purity, safety and performance standards for gases and equipment across therapeutic, diagnostic and manufacturing uses, which together form an essential part of the country’s healthcare operations.

In Australia the main end-users of medical gases and associated equipment include hospitals, home-healthcare providers, ambulatory surgical centres, pharmaceutical and biotechnology companies and academic and research institutions each operating within distinct frameworks. Hospitals in cities like Sydney, Melbourne and Perth maintain centralised gas systems comprising storage tanks, pipeline networks, manifold systems and vacuum stations that supply oxygen, nitrous oxide and medical air to surgical, emergency and intensive-care departments. Home-healthcare services across Australia provide portable oxygen concentrators, cylinders and related equipment to patients requiring long-term respiratory support in regional and remote communities such as those in the Northern Territory and outback Queensland. Ambulatory surgical centres in metropolitan areas such as Brisbane and Adelaide use compact gas delivery systems and mobile cylinders for outpatient surgeries and anaesthetic procedures. Pharmaceutical and biotechnology companies operating in innovation hubs like Melbourne’s Parkville precinct and Sydney’s Macquarie Park integrate ultra-high-purity gas systems and precision-engineered delivery equipment into their manufacturing and laboratory processes. Academic and research institutions including the University of Queensland and Monash University maintain specialised pipeline installations, cryogenic gas storage and laboratory delivery systems that support biomedical research and clinical training. Each end-user sector in Australia is supported by a framework of safety standards, maintenance programs and compliance systems that ensure reliable supply and proper use of medical gases and related equipment across diverse healthcare environments. 

Considered in this report
• Historic Year: 2019
• Base year: 2024
• Estimated year: 2025
• Forecast year: 2030

Aspects covered in this report
• Medical Gas and Equipment Market with its value and forecast along with its segments
• Various drivers and challenges
• On-going trends and developments
• Top profiled companies
• Strategic recommendation

By Product Type
• Medical Gases
• Medical Gas Equipment

By Application
• Therapeutic
• Diagnostic
• Pharmaceutical Industry
• Others

By End-User
• Hospitals
• Home Healthcare
• Ambulatory Surgical Centers
• Pharmaceutical & Biotechnology Companies
• Academic & Research Institutions Show more